{"title":"Chromophobe renal cell carcinoma: An unexpected finding in a pelvic ultrasound","authors":"Cynthia Dawes","doi":"10.1002/sono.12301","DOIUrl":null,"url":null,"abstract":"‘Chromophobe’ is the third most common subtype of renal cell carcinoma (RCC) accounting for 5% of cases. Chromophobe renal cell carcinoma (chRCC) mostly presents sporadically (non-hereditary) but also is commonly demonstrated in people with Birt-Hogg-Dube (BHD) syndrome. The majority of chRCC are diagnosed in stages I or II and has a similar incidence in women (52%) and men (48%). ChRCC has a metastatic potential of 6%–7% with the most common sites to be liver, lung and retroperitoneal lymph nodes. Overall, chRCC has a better prognosis than other subtypes with a survival rate of approximately 90% at 5 years. This case study discusses an unexpected finding of chRCC during a pelvic ultrasound, the use of computed tomography (CT) diagnostic imaging for further characterisation and histological testing to gain accurate diagnosis. 2 | CASE DESCRIPTION","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"46 1","pages":"92 - 96"},"PeriodicalIF":0.4000,"publicationDate":"2022-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sonography","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/sono.12301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
‘Chromophobe’ is the third most common subtype of renal cell carcinoma (RCC) accounting for 5% of cases. Chromophobe renal cell carcinoma (chRCC) mostly presents sporadically (non-hereditary) but also is commonly demonstrated in people with Birt-Hogg-Dube (BHD) syndrome. The majority of chRCC are diagnosed in stages I or II and has a similar incidence in women (52%) and men (48%). ChRCC has a metastatic potential of 6%–7% with the most common sites to be liver, lung and retroperitoneal lymph nodes. Overall, chRCC has a better prognosis than other subtypes with a survival rate of approximately 90% at 5 years. This case study discusses an unexpected finding of chRCC during a pelvic ultrasound, the use of computed tomography (CT) diagnostic imaging for further characterisation and histological testing to gain accurate diagnosis. 2 | CASE DESCRIPTION